- Research works
- 17 ▲ 156% vs 2018-21
- Citations
- 83 4.8 per fractional work
- Top-10% rate
- 1.2% all institutions 10.0%
- Open access
- 15% world 40%
- International
- 12% world 18%
Not ranked overall: BioLamina (Sweden) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does BioLamina (Sweden) work in?
In all years, 54% of research at BioLamina (Sweden) is in Life Sciences, 31% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (50%), Medicine (31%), Engineering (7%). It does 2.2× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 3 domains and 8 fields, with their numbers
- Life Sciences953.5%
- Health Sciences531.3%
- Medicine531.3%
- Physical Sciences315.2%
- Engineering16.9%
- Computer Science15.8%
- Materials Science02.5%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.2×. Every wedge is a field page.
All 6 fields, with their numbers
- Biochemistry, Genetics and Molecular Biology7.22×3 works
- Medicine2.07×3 works
- Computer Science1.60×1 works
- Engineering0.55×1 works
- Materials Science0.17×0 works
- Agricultural and Biological Sciences0.10×0 works
Who are the top researchers at BioLamina (Sweden)?
Ranked on the quality score, Therése Kallur lead among researchers whose main affiliation is BioLamina (Sweden).
- 1
Therése Kallur
Sweden · #1,215,382 worldwide 1.6k citations · 27 works
Which research topics does BioLamina (Sweden) publish most on?
By volume in 2022-now: Viral Infectious Diseases and Gene Expression in Insects, CAR-T cell therapy research, 3D Printing in Biomedical Research and Chemical Synthesis and Analysis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
- 2 CAR-T cell therapy research Oncology 1 works
- 3 3D Printing in Biomedical Research Biomedical Engineering 1 works
- 4 Chemical Synthesis and Analysis Molecular Biology 0 works
- 5 Pancreatic function and diabetes Surgery 0 works
- 6 Diabetes and associated disorders Genetics 0 works
- 7 Computational Geometry and Mesh Generation Computer Graphics and Computer-Aided Design 0 works
- 8 Renal and related cancers Molecular Biology 0 works
- 9 Dermatology and Skin Diseases Dermatology 0 works
- 10 Mathematics, Computing, and Information Processing Computational Theory and Mathematics 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has BioLamina (Sweden)'s research output changed?
Output in 2022-2025 was 156% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is BioLamina (Sweden) as a percentage of every work published that year, 0.000036% in 2024.
Fractional works of BioLamina (Sweden) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Sundbyberg
- Swedish Chemicals Agency
- Heat Management (Sweden)
- Guideline Geo (Sweden)
- Iamip (Sweden)
- Diabetesförbundet
- Diabetesfonden
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about BioLamina (Sweden). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.